Published in Tex Heart Inst J on January 01, 1998
Postoperative care of the transplanted patient. Curr Cardiol Rev (2011) 0.75
Lessons learned in pediatric heart transplantation. Ann Thorac Surg (1989) 2.46
The Registry of the International Society for Heart Transplantation: seventh official report--1990. J Heart Transplant (1990) 1.23
Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group. J Heart Lung Transplant (1994) 1.14
The Registry of the International Society for Heart and Lung Transplantation: eleventh official report--1994. J Heart Lung Transplant (1994) 0.99
Should cardiac transplantation for congenital heart disease be delayed until adult age? Eur J Cardiothorac Surg (1994) 0.91
Orthotopic heart transplantation for congenital heart disease. Technical considerations. Eur J Cardiothorac Surg (1993) 0.88
Orthotopic heart transplantation for complex congenital heart disease. J Thorac Cardiovasc Surg (1990) 0.87
Expanding applicability of transplantation after multiple prior palliative procedures. The Paediatric Heart Transplant Group. Ann Thorac Surg (1991) 0.86
Pediatric cardiac transplantation for congenital heart defects: surgical considerations and results. Ann Thorac Surg (1993) 0.86
Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol (1994) 0.84
Heart transplantation in children with congenital heart disease. J Am Coll Cardiol (1995) 0.84
Pediatric heart transplantation: results of 2- and 5-year follow-up. J Heart Lung Transplant (1994) 0.83
Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. J Am Coll Cardiol (1994) 0.82
Pediatric heart transplantation. Ann Thorac Surg (1989) 0.82
Pediatric heart transplantation at Stanford: results of a 15-year experience. Pediatrics (1991) 0.82
Orthotopic heart transplantation in children with congenital heart disease. Ann Thorac Surg (1994) 0.81
Endomyocardial biopsy after heart transplantation in children. J Heart Transplant (1988) 0.79
Pediatric cardiac transplantation. The Stanford experience. Circulation (1994) 0.78
Method for cardiac transplantation in corrected transposition of the great arteries. J Cardiovasc Surg (Torino) (1982) 0.78
Cardiac transplantation in infants and children. Ann Thorac Surg (1994) 0.78
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. A rebuttal. J Thorac Cardiovasc Surg (2003) 5.03
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res (1999) 4.57
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg (2014) 3.28
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA (2001) 2.89
Metabolic gene expression in fetal and failing human heart. Circulation (2001) 2.59
The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation (2001) 2.24
Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg (1989) 2.17
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J (2002) 2.17
Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol (2008) 2.07
Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg (1992) 2.06
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Complete resection of a right atrial intracavitary metastatic melanoma. Ann Thorac Surg (1996) 1.95
Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest (2000) 1.91
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med (2001) 1.78
Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation (1997) 1.76
Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res (2000) 1.72
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1984) 1.71
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg (1990) 1.69
Subacute postictal aggression. Neurology (1998) 1.68
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Failure to detect connexin43 mutations in 38 cases of sporadic and familial heterotaxy. Circulation (1996) 1.65
Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J (2000) 1.65
Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet (1996) 1.65
Bedside right ventricular assist device removal in the conscious patient. Ann Thorac Surg (2007) 1.63
End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant (2007) 1.60
Bacterial mediastinitis after heart transplantation. J Heart Lung Transplant (1992) 1.56
Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet (1994) 1.55
Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg (2004) 1.54
Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Ann Thorac Surg (2008) 1.54
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation. J Heart Lung Transplant (1994) 1.52
Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology (1993) 1.52
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.51
Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J (2005) 1.49
Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.48
Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant (2005) 1.47
Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg (2008) 1.46
Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. Ann Thorac Surg (1991) 1.45
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation (1999) 1.44
Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. J Thorac Cardiovasc Surg (1984) 1.43
The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz (2000) 1.42
Effect of pump flow mode of novel left ventricular assist device upon end organ perfusion in dogs with doxorubicin induced heart failure. ASAIO J (2005) 1.41
Thrombogenicity of mechanical aortic valves in an animal model: site specific testing is crucial. ASAIO J (2004) 1.39
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg (2009) 1.39
Cardiac transplantation in Puerto Rican patients at the Texas Heart Institute. Bol Asoc Med P R (1991) 1.39
Closed head injury resulting in paradoxical improvement of a seizure disorder. Seizure (2000) 1.39
Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant (2011) 1.38
The AbioCor implantable replacement heart. Ann Thorac Surg (2003) 1.38
Preclinical assessment of a trileaflet mechanical valve in the mitral position in a calf model. Ann Thorac Surg (2004) 1.38
Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J (2011) 1.37
The use of pyloric exclusion in the management of severe duodenal injuries. Am J Surg (1977) 1.36
Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation (2000) 1.36
Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology (2002) 1.33
Human cardiac explantation and autotransplantation: application in a patient with a large cardiac pheochromocytoma. Tex Heart Inst J (1985) 1.29
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology. Eur Heart J (1999) 1.29
Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease. Circulation (1999) 1.28
Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet (1999) 1.27
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
A system for grading cardiac allograft rejection. Tex Heart Inst J (1986) 1.25
Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. J Heart Lung Transplant (2003) 1.22
Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. J Heart Lung Transplant (2005) 1.21
Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med (1998) 1.20
Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant (2006) 1.19
Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model. Ann Thorac Surg (1999) 1.18
Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation (1997) 1.17
Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med (1998) 1.14
Pulsatile and nonpulsatile flows can be quantified in terms of energy equivalent pressure during cardiopulmonary bypass for direct comparisons. ASAIO J (2000) 1.13
Intrapericardial pheochromocytoma. Am J Med (1983) 1.13
Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. Circulation (1999) 1.13
Monitoring regional cerebral oxygen saturation using near-infrared spectroscopy during pulsatile hypothermic cardiopulmonary bypass in a neonatal piglet model. ASAIO J (2000) 1.13